Published in Lancet on September 01, 2001
Occurrence of mycobacteria in water treatment lines and in water distribution systems. Appl Environ Microbiol (2002) 1.78
Chlorine disinfection of atypical mycobacteria isolated from a water distribution system. Appl Environ Microbiol (2002) 1.50
Mycobacteria in water and loose deposits of drinking water distribution systems in Finland. Appl Environ Microbiol (2004) 1.34
Mycobacterium tuberculosis complex mycobacteria as amoeba-resistant organisms. PLoS One (2011) 1.22
Outbreak of nontuberculous mycobacterial subcutaneous infections related to multiple mesotherapy injections. J Clin Microbiol (2009) 0.95
Mycobacterium xenopi and drinking water biofilms. Appl Environ Microbiol (2003) 0.89
Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis (2008) 0.87
Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clin Microbiol Rev (2016) 0.84
Spondylitis due to Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literature. J Clin Microbiol (2005) 0.81
Monitoring the one year postoperative infection rate after primary total hip replacement. Int Orthop (2011) 0.79
Complete genome sequence of Mycobacterium xenopi type strain RIVM700367. J Bacteriol (2012) 0.75
Does an information leaflet about surgical site infection (SSI) improve recollection of information and satisfaction of patients? A randomized trial in patients scheduled for digestive surgery. World J Surg (2011) 0.75
Colonization of Hospital Water Networks by Gemmata massiliana, a New Planctomycetes Bacterium. Curr Microbiol (2015) 0.75
Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol (2000) 8.10
High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A (2001) 6.97
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis (1991) 4.74
hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol (1999) 3.99
Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg Infect Dis (2001) 3.89
Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis (2001) 3.82
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother (2005) 3.81
The challenge of tuberculosis: statements on global control and prevention. Lancet (1995) 3.19
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 3.02
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice. Antimicrob Agents Chemother (1993) 2.97
Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis (2003) 2.92
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis. Antimicrob Agents Chemother (2005) 2.74
Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol (1997) 2.67
Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments. Tubercle (1991) 2.59
Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis (1992) 2.55
Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors. Am J Hum Genet (1995) 2.51
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. Antimicrob Agents Chemother (1990) 2.46
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol (2001) 2.38
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. Antimicrob Agents Chemother (1994) 2.34
Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphism analysis, spoligotyping, and variable number of tandem DNA repeats. J Clin Microbiol (2001) 2.22
Tuberculous meningitis in France in 1990: characteristics and impact of BCG vaccination. Tuber Lung Dis (1994) 2.21
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis (2004) 2.20
Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol (1998) 2.17
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. Antimicrob Agents Chemother (1991) 2.08
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. Antimicrob Agents Chemother (2001) 1.98
Impact of BCG on tuberculous meningitis in France in 1990. Lancet (1992) 1.97
Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis (1997) 1.96
Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med (1999) 1.92
The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy. Bull Int Union Tuberc (1978) 1.92
Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother (2001) 1.90
[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]. Pathol Biol (Paris) (1982) 1.90
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections. Eur J Clin Microbiol Infect Dis (2004) 1.89
Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains. J Infect Dis (1988) 1.86
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 1.80
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. Antimicrob Agents Chemother (2000) 1.79
In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis. Tubercle (1991) 1.77
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Antimicrob Agents Chemother (1991) 1.77
Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med (1980) 1.76
Syndromic surveillance based on emergency department activity and crude mortality: two examples. Euro Surveill (2006) 1.73
DNA probe specific for Legionella pneumophila. J Clin Microbiol (1985) 1.73
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis (1994) 1.71
Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect (2001) 1.70
Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol (1998) 1.68
Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans. J Clin Microbiol (2002) 1.67
Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis (2004) 1.67
A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology (1989) 1.64
Genomic sequence and transcriptional analysis of a 23-kilobase mycobacterial linear plasmid: evidence for horizontal transfer and identification of plasmid maintenance systems. J Bacteriol (2001) 1.64
Mycobacterial infections in domestic and wild animals due to Mycobacterium marinum, M. fortuitum, M. chelonae, M. porcinum, M. farcinogenes, M. smegmatis, M. scrofulaceum, M. xenopi, M. kansasii, M. simiae and M. genavense. Rev Sci Tech (2001) 1.60
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J Infect Dis (1994) 1.60
Preparation by two-dimensional electrophoresis of proteins for antibody production: antibodies against proteins whose synthesis is reduced by auxin in tobacco mesophyll protoplasts. Electrophoresis (1988) 1.55
Isolation of specific DNA fragments of Mycobacterium avium and their possible use in diagnosis. J Clin Microbiol (1993) 1.55
Typing of Mycobacterium avium isolates by PCR. J Clin Microbiol (1996) 1.52
A blind study of the polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA. Azay Mycobacteria Study Group. Tuber Lung Dis (1996) 1.49
Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum. J Clin Microbiol (2001) 1.49
Laparoscopic adjustable gastric banding. World J Surg (1998) 1.48
Rapid discrimination of Mycobacterium tuberculosis complex strains by ligation-mediated PCR fingerprint analysis. J Clin Microbiol (1997) 1.47
The new quinolones and their combinations with other agents for therapy of severe infections. J Antimicrob Chemother (1986) 1.46
Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice? Antimicrob Agents Chemother (1997) 1.46
Leprosy and BCG in southern Vietnam. Lancet (1990) 1.44
Results of blood cultures for detection of mycobacteria in AIDS patients. Tubercle (1989) 1.43
Ofloxacin for the treatment of leprosy. Acta Leprol (1991) 1.41
Adverse effects of rifampin. Rev Infect Dis (1983) 1.40
[Knowledge, opinions and tobacco consumption in a French faculty of medicine]. Presse Med (2003) 1.39
[Pasteurellosis in an HIV infected patient]. Presse Med (1993) 1.38
Comparative evaluation of PCR and commercial DNA probes for detection and identification to species level of Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol (1996) 1.38
Identification of Shigella boydii in colonic malacoplakia by universal bacterial 16S ribosomal DNA-based amplification in a human immunodeficiency virus-infected patient. Clin Infect Dis (1999) 1.38
Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care (2003) 1.38
Molecular characterization of Mycobacterium avium complex isolates giving discordant results in AccuProbe tests by PCR-restriction enzyme analysis, 16S rRNA gene sequencing, and DT1-DT6 PCR. J Clin Microbiol (1997) 1.35
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist (2005) 1.33
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med (1993) 1.32
Iron and Mycobacterium tuberculosis infection. J Clin Virol (2001) 1.28
Molecular markers demonstrate that the first described multidrug-resistant Mycobacterium bovis outbreak was due to Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.28
Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect (2002) 1.28
HIV-2 infection in two homosexual men in France. Lancet (1987) 1.27
Isolation of an unusual Mycobacterium species from an AIDS patient with acute lymphadenitis. J Clin Microbiol (2000) 1.24
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strains. J Clin Microbiol (1999) 1.23
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. Antimicrob Agents Chemother (1992) 1.22
Is PCR a useful tool for the diagnosis of tuberculosis in 1995? Tuber Lung Dis (1995) 1.22
Urease-positive thermophilic Campylobacter (Campylobacter laridis variant) isolated from an appendix and from human feces. J Clin Microbiol (1988) 1.20
Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia. J Clin Microbiol (1997) 1.17
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse]. Rev Mal Respir (1985) 1.15
Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. Am J Respir Crit Care Med (1999) 1.15
Homing events in the gyrA gene of some mycobacteria. Proc Natl Acad Sci U S A (1996) 1.13
Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection). Eur Respir J (1992) 1.13
Native valve endocarditis caused by Staphylococcus capitis. Eur J Clin Microbiol Infect Dis (1993) 1.13
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens. Am J Respir Crit Care Med (2000) 1.13
Mycobacterium xenopi IS1395, a novel insertion sequence expanding the IS256 family. Microbiology (1996) 1.12
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease. Eur Respir J (2005) 1.12
Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis. Am J Respir Crit Care Med (1998) 1.11
Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect (2002) 1.11
Assessing residents' prescribing behavior in renal impairment. Int J Qual Health Care (2003) 1.10
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin. J Antimicrob Chemother (1995) 1.09
Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases. J Acquir Immune Defic Syndr (1993) 1.09
Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses. J Clin Microbiol (1999) 1.09
Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis (1999) 1.08